16Aug 2023
Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies

Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies

The study focuses on improving adjuvant treatment decisions for endometrial cancer by considering molecular subtypes. POLE mutated cases consistently showed positive outcomes. Similarities between p53 abnormality endometrial cancer and high-grade serous ovarian cancer suggested overlapping treatments. Immune checkpoint molecules counteracted immune issues in mismatch repair deficient cases. Hormonal treatment was suggested for high-risk non-specific molecular spectrum cases. Overall, combining clinical and molecular data could enhance treatment selection, involving radiochemo-, chemotherapy, inhibitors, endocrine therapy, and immunotherapy.

  • #gynaecology - ivf

Like

Save

Share